Management ChangeAug 4, 2026, 07:08 AM
Eton Pharmaceuticals Appoints Danka Radosavljevic as COO
AI Summary
Eton Pharmaceuticals, Inc. announced the appointment of Danka Radosavljevic as its new Chief Operating Officer, effective July 31, 2026. Ms. Radosavljevic, who joined the company in 2017, previously held the position of Executive Vice President, Operations for over five years, overseeing critical functions including quality, product development, regulatory, supply chain, and information systems. Her compensation package includes an annual base salary of $520,800 and a target annual discretionary incentive bonus of 50% of her base salary.
Key Highlights
- Danka Radosavljevic appointed Chief Operating Officer (COO) of Eton Pharmaceuticals.
- Ms. Radosavljevic previously served as Executive Vice President, Operations for over five years.
- She has been with Eton Pharmaceuticals since 2017.
- Her annual base salary is set at $520,800.
- She is eligible for an annual discretionary incentive bonus targeting 50% of her base salary.
Price Impact
More from ETON